Static Chart AprilBio Co.,Ltd.

Equities

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-06-26 EDT			5-day change	1st Jan Change
18,500 ^KRW	-4.10%		+23.50%	+9.79%

06-24	Evommune, Inc. Secures Exclusive Rights to Develop and Commercialize a Phase 2-Ready IL-18 Targeted Fusion Protein from AprilBio	CI
2023	AprilBio Co.,Ltd.(KOSDAQ:A397030) added to S&P Global BMI Index	CI

Duration

Period